Raymond Dennis Pratt - 12 Dec 2024 Form 4 Insider Report for Savara Inc (SVRA)

Role
Chief Medical Officer
Signature
/s/ David Lowrance as attorney-in-fact for Raymond Pratt
Issuer symbol
SVRA
Transactions as of
12 Dec 2024
Net transactions value
$0
Form type
4
Filing time
16 Dec 2024, 17:57:41 UTC
Previous filing
12 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SVRA Common Stock Award $0 +80,000 +31% $0.000000 340,050 12 Dec 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SVRA Stock Option (Right to Buy) Award $0 +280,000 $0.000000 280,000 12 Dec 2024 Common Stock 280,000 $3.35 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") that vest in full on December 12, 2026, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2 The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of December 12, 2024, subject to the reporting person's continued service with the Issuer.